Laminaria japonica Aresch‐Derived Fucoidan Ameliorates Hyperlipidemia by Upregulating LXRs and Suppressing SREBPs
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2024 (1) , 8649365
Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide, and hyperlipidemia is one major inducing factor of CVD. It is worthy to note that fucoidans are reported to have hypolipidemic activity with species specificity; however, the underlying mechanisms of action are far from clarification. This study is aimed at investigating the plasma lipid‐lowering mechanisms of the fucoidan from L. japonica Aresch by detecting the levels of hepatic genes that are involved in lipid metabolism. Our results demonstrated that the fucoidan F3 significantly lowered total cholesterol and triglyceride in C57BL/6J mice fed a high‐fat diet. In the mouse liver, fucoidan F3 intervention significantly increased the gene expression of peroxisome proliferator‐activated receptor (PPAR) α, liver X receptor (LXR) α and β, and ATP‐binding cassette transporter (ABC) G1 and G8 and decreased the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), low‐density lipoprotein receptor, cholesterol 7 alpha‐hydroxylase A1, and sterol regulatory element‐binding protein (SREBP) 1c and SREBP‐2. These results demonstrated that the antihyperlipidemic effects of fucoidan F3 are related to its activation of PPARα and LXR/ABC signaling pathways and inactivation of SREBPs. In conclusion, fucoidan F3 may be explored as a potential compound for prevention or treatment of lipid disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82271803, 82070469)
This publication has 41 references indexed in Scilit:
- Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulationJournal of Pharmacological Sciences, 2016
- Structure and hypolipidaemic activity of fucoidan extracted from brown seaweedSargassum henslowianumNatural Product Research, 2014
- Effect of Fucoidan Administration on Insulin Secretion and Insulin Resistance in Overweight or Obese AdultsJournal of Medicinal Food, 2014
- Fucoidan from the sea cucumber Acaudina molpadioides exhibits anti-adipogenic activity by modulating the Wnt/β-catenin pathway and down-regulating the SREBP-1c expressionFood & Function, 2014
- Hypolipidemic effect of fucoidan fromLaminaria japonicain hyperlipidemic ratsPharmaceutical Biology, 2010
- Fenofibrate Reduces Atherogenesis in ApoE*3Leiden MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patientsEuropean Journal of Clinical Pharmacology, 2003
- Regulation of lipid metabolism and gene expression by fenofibrate in hamstersBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2001
- Analysis of sulfate in complex carbohydratesAnalytical Biochemistry, 1982
- A modified uronic acid carbazole reactionAnalytical Biochemistry, 1962